Achieving >70% AMI-CS Survival: Insight From National Cardiogenic Shock Initiative

Presented by William O'Neill, MD View our full TCT Connect coverage o...

Panoulas Paper on Impella Experience in the UK

Impella® Support: Clinical Utility, Indications, and Outcomes Vasileios Panoulas, MD, PhD, MRCP, FESC...

Optimal Target MAP in Post-Cardiac Arrest AMI Shock

MAP between 80 and 100 mmHg Reduces Myocardial Injury Do blood pressure targets in the 36 hours after...

Schäfer Paper on Impella® Heart Pump Use in AMI Cardiogenic Shock

Influence of Impella Treatment Timing and Predicted Risk on Mortality Prof. Andreas Schäfer, MD discu...

Keller Paper on LV Unloading in ECMO

Better Than Anticipated Survival with Impella CP® and ECMO in Cardiogenic Shock Steven P. Keller, MD,...

Lemor Paper Comparing Impella to ECMO in AMICS

Impella vs ECMO: Clinical Outcomes, Complications, Length of Stay, and Cost Dr. Alejandro Lemor discu...

Hanson Paper on Survival in AMICS

SCAI Shock Classification Helps Predict Survival Ivan Hanson, MD discusses his recently published pap...

Ramzy Paper: First Published Clinical Experience on Impella 5.5 with SmartAssist for Cardiogenic Shock

Impressive Survival and Heart Recovery Rates with Impella 5.5 Danny Ramzy, MD discusses his experienc...

Pappalardo Paper on Bedside Impella® Insertion

ICU Impella Insertion with TEE Guidance in Cardiogenic Shock Federico Pappalardo, MD discusses his re...

Mechanical Circulatory Support in AMI Cardiogenic Shock

Insights on MCS Use and Timing from Dr. Jacob Møller in Denmark Jacob Møller MD, PhD, an intensivist...

Revascularization Strategies for Multivessel CAD

Retrospective Analysis from NCSI of Multivessel Intervention With Impella for AMI Shock Dr. Bill O’Neill...

National Trends on the Incidence and Clinical Outcomes of Stroke

How common is it to see stroke in a patient with cardiogenic shock? Navin Kapur, MD, FAHA, FACC, FSCAI, is the executi...

Managing Acute MI Cardiogenic Shock

Developing Best Practices with Dr. Bill O’Neill “What are the foundations for developing best practices in managing ac...

National Cardiogenic Shock Initiative Update

Dr. Bill O’Neill Discusses Ongoing Progress in NCSI Bill O’Neill, MD presents some of the overall out...

Top Cardiogenic Shock Treatment Objectives and Device Options

What is Cardiogenic Shock? Cardiogenic shock is a life-threatening condition that occurs when the heart can no longer...

NCSI Findings Regarding Right Ventricular Dysfunction

About 40% of AMICS Patients Develop Right Ventricular Dysfunction Dr. Babar Basir, an interventionalist at Henry Ford...

Multicenter Impella Experience Data from Dr. Andreas Schäfer

Impella for AMI Cardiogenic Shock Dr. Andreas Schäfer, an interventional cardiologist and intensivist from Hannover, G...

Duane Pinto Comments on SCAI Vascular Access and Closure Best Practices

A Practical Resource for Practicing Physicians Duane Pinto, MD, MPH, one of the nation’s experts on v...

Where’s the Cardiogenic Shock Treatment Data?

Looking to Real-world Evidence in Cardiogenic Shock Dr. William O’Neill discusses...

Clinical Paper: Beyond Reperfusion by Jerry Curran

Acute Ventricular Unloading and Cardioprotection During MI Jerry Curran PhD, Senior Scientist at Abio...

Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women

Reference: J Interven Cardiol 2016; 29:248–256. Card...

INOVA Heart and Vascular Heart Recovery Initiative

Instituting a Cardiogenic Shock Protocol to Improve Outcomes Alexander Truesdell, MD and Behnam Tehrani, MD, intervent...

Dr. Bill O’Neill: New Data from NCSI & Improving Outcomes in Cardiogenic Shock

“This is a coalition of the willing…I think all of you have to decide tomorrow when you go home, in your hospital h...

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...

National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) data...